Company / Operating Cash Flow per Share
Pasithea Therapeutics Corp. Operating Cash Flow per Share History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.14
FY2022
5-year range
-$0.14 / -$0.01
FY2021-FY2022
Trend
-2563.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-0.14 in FY2022.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating cash flow per share decreased 2563.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$0.14 | -2563.2% |
| FY2021 | -$0.01 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026